Richard M. Mangano

3.1k total citations · 1 hit paper
35 papers, 2.4k citations indexed

About

Richard M. Mangano is a scholar working on Experimental and Cognitive Psychology, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Richard M. Mangano has authored 35 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Experimental and Cognitive Psychology, 11 papers in Cognitive Neuroscience and 10 papers in Clinical Psychology. Recurrent topics in Richard M. Mangano's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers), Sleep and Wakefulness Research (8 papers) and Perfectionism, Procrastination, Anxiety Studies (7 papers). Richard M. Mangano is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers), Sleep and Wakefulness Research (8 papers) and Perfectionism, Procrastination, Anxiety Studies (7 papers). Richard M. Mangano collaborates with scholars based in United States, Canada and Sweden. Richard M. Mangano's co-authors include Robert Schwarcz, William O. Whetsell, Robert Schwarcz, Maiko Fujimori, Sonia Ancoli‐Israel, James K. Walsh, Martin B. Scharf, Michael R. Liebowitz, Gregory M. Asnis and Mark H. Pollack and has published in prestigious journals such as Science, Gastroenterology and Brain Research.

In The Last Decade

Richard M. Mangano

34 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain

1983 1.1k citations Robert Schwarcz, William O. Whetsell et al. Science profile →

Peers

Countries citing papers authored by Richard M. Mangano

Since Specialization

Citations

This map shows the geographic impact of Richard M. Mangano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Mangano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Mangano more than expected).

Fields of papers citing papers by Richard M. Mangano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Mangano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Mangano. The network helps show where Richard M. Mangano may publish in the future.

Co-authorship network of co-authors of Richard M. Mangano

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Mangano. A scholar is included among the top collaborators of Richard M. Mangano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Mangano. Richard M. Mangano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mo2084 CB-5945 0.25 mg Twice Daily Is Associated With Significantly Increased Spontaneous Bowel Movement and Greater Proportion of Responders Compared With Placebo in Patients on Chronic Opioid Therapy for Noncancer Pain (45CL242; NCT01207427) 2012 ·Gastroenterology ·Neil Singla, Lee Techner, K. Gabriel, Richard M. Mangano	6
2	A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder 2009 ·The Journal of Clinical Psychiatry ·Michael R. Liebowitz, Gregory M. Asnis, Richard M. Mangano, Evan Tzanis	30
3	A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder 2007 ·Psychopharmacology ·Mark H. Pollack, Richard M. Mangano, Richard Entsuah, Evan Tzanis, Naomi M. Simon	47
4	Relapse Prevention of Panic Disorder in Adult Outpatient Responders to Treatment With Venlafaxine Extended Release 2007 ·The Journal of Clinical Psychiatry ·James M. Ferguson, Arif Khan, Richard M. Mangano, Richard Entsuah, Evan Tzanis	25
5	Sleep and Residual Sedation After Administration of Zaleplon, Zolpidem, and Placebo During Experimental Middle-of-the-Night Awakening 2006 ·Journal of Clinical Sleep Medicine ·Gary Zammit, Bruce Corser, Karl Doghramji, June M. Fry, Steven James, Andrew D. Krystal, Richard M. Mangano	33
6	A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder 2005 ·The Journal of Clinical Psychiatry ·Michael R. Liebowitz, Richard M. Mangano, Jacques Bradwejn, Gregory M. Asnis	78
7	Long-term use of sedative hypnotics in older patients with insomnia 2005 ·Sleep Medicine ·Sonia Ancoli‐Israel, Gary S. Richardson, Richard M. Mangano, Lisa M. Jenkins, Phil Hall, Walter S. Jones	88
8	Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial 2004 ·Psychopharmacology ·Murray B. Stein, Mark H. Pollack, Alexander Bystritsky, Jeffrey E. Kelsey, Richard M. Mangano	78
9	A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder 2004 ·Journal of Clinical Psychopharmacology ·Karl Rickels, Richard M. Mangano, Arifulla Khan	70
10	Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double‐blind, placebo‐controlled, parallel‐group comparison with paroxetine 2004 ·Human Psychopharmacology Clinical and Experimental ·Christer Allgulander, Richard M. Mangano, Jun Zhang, Alv A. Dahl, Ulla Lepola, Ingemar Sjödin, Gérard Emilien	74
11	Treating social anxiety disorder with venlafaxine extended release 2002 ·European Neuropsychopharmacology ·Richard M. Mangano	3
12	Zaleplon improves sleep without producing rebound effects in outpatients with insomnia 2000 ·International Clinical Psychopharmacology ·June M. Fry, Martin B. Scharf, Richard M. Mangano, Maiko Fujimori	67
13	Dose‐response effects of zaleplon as compared with triazolam (0·25 mg) and placebo in chronic primary insomnia 2000 ·Human Psychopharmacology Clinical and Experimental ·Christopher L. Drake, Timothy Roehrs, Richard M. Mangano, Thomas Roth	17
14	Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects 1999 ·The Primary Care Companion For CNS Disorders ·Sonia Ancoli‐Israel, James K. Walsh, Richard M. Mangano, Maiko Fujimori	105
15	The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives 1993 ·Journal of Medicinal Chemistry ·Eugene J. Trybulski, Jing Zhang, (unknown), Richard M. Mangano	20
16	Interleukin-1β decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats 1991 ·Brain Research ·Pedro Rada, Gregory P. Mark, Michael P. Vitek, Richard M. Mangano, Arthur J. Blume, Bernard Beer, Bartley G. Hoebel	110
17	Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogs of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5) 1990 ·Journal of Medicinal Chemistry ·Eugene J. Trybulski, (unknown), Richard M. Mangano, (unknown)	13
18	Modulation of ligand binding to muscarinic cholinergic receptors 1986 ·The Society for Neuroscience Abstracts ·(unknown), Richard M. Mangano	1
19	Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain breakdown → 1983 ·Science ·Robert Schwarcz, William O. Whetsell, Richard M. Mangano	1074
20	Huntington's disease 1982 ·Journal of the Neurological Sciences ·Richard M. Mangano, Robert Schwarcz	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact